• Crescent Biopharma set inducement equity awards for two non-executive hires, granting options covering 16,950 ordinary shares.
• Options carry a 10-year term with an exercise price of $21.47, set at the May 28 Nasdaq closing price.
• Vesting starts with 25% on the first anniversary of each employee’s start date, then monthly vesting of the remainder.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crescent Biopharma Inc. published the original content used to generate this news brief on May 29, 2026, and is solely responsible for the information contained therein.